Atropine Sulfate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Dec 20, 2023.
Shortage details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0641-6251-10
- Dosage Form
- Injection
- Presentation
- Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10)
- Initial Posting
- Dec 20, 2023